ARTICLE | Financial News
Cell Innovation Partners L.P. financial update
October 6, 2014 7:00 AM UTC
ReproCell markets induced pluripotent stem cell (iPSC)-derived cardiomyocytes, neurons and hepatocytes for drug discovery. The company also markets primary cells for diabetes research and media and re...